Quantification of sinking pre beta lipoprotein in human plasma

Area of Science:

• Biochemistry
• Clinical Chemistry
• Cardiovascular Research

Background:

• Plasma cholesterol transport involves low-density lipoproteins (LDL), including beta-lipoprotein and its genetic variant, sinking pre-beta-lipoprotein (SPB).
• Accurate quantification of cholesterol within these subfractions is crucial for understanding lipid metabolism and cardiovascular disease risk.

Purpose of the Study:

• To develop and validate a method for quantifying cholesterol in isolated human plasma beta-lipoprotein and sinking pre-beta-lipoprotein (SPB).
• To assess the accuracy and precision of the proposed quantification method for SPB cholesterol.

Main Methods:

• Isolation of beta-lipoprotein and SPB from human plasma using ultracentrifugation and gel filtration.
• Agarose gel electrophoresis followed by Sudan Black B staining and optical densitometry for lipoprotein quantification.
• Development of a formula to estimate SPB cholesterol based on optical density measurements and total cholesterol content.

Main Results:

• The staining intensity of both lipoproteins was proportional to their cholesterol content within specific ranges (SPB: 2-50 mg/dl, beta-lipoprotein: 50-250 mg/dl).
• The developed formula estimated SPB cholesterol with a mean deviation of 6% compared to true values, irrespective of beta-lipoprotein concentration.
• The method demonstrated a coefficient of variation of 5-10% for SPB cholesterol concentrations of 6-30 mg/dl, with a detection limit of 1-2 mg/dl.

Conclusions:

• A reliable method for estimating cholesterol distribution between SPB and beta-lipoprotein subfractions was established.
• This quantification technique provides valuable insights into LDL cholesterol composition.
• The method holds potential for improving the assessment of atherosclerosis risk by differentiating cholesterol levels in lipoprotein subfractions.